Tag archive for ‘Nestlé Health Science’
Nestlé to acquire core brands of vitamins and nutritional supplements manufacturer Bountiful
By businessnewstoday On Saturday, May 1st, 2021

Nestlé to acquire core brands of vitamins manufacturer Bountiful for $5.7bn

Nestlé has signed a deal worth $5.75 billion with KKR to acquire core brands of Bountiful, a US manufacturer of vitamins and nutritional supplements. Included in the deal are Bountiful’s brands – Nature’s More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, November 8th, 2020

Seres Therapeutics begins phase 1b trial of SER-301 in ulcerative colitis

Seres Therapeutics has dosed the first patient in a phase 1b clinical trial, which is assessing SER-301 for the treatment of active mild-to-moderate ulcerative colitis (UC). According to the US-based biotech company, More...

By pharmanewsdaily On Tuesday, September 1st, 2020

Nestlé to fully own Aimmune Therapeutics through $2bn deal

Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in the latter for about $2 billion. The deal is expected More...

By pharmanewsdaily On Friday, June 12th, 2020

Nestlé to acquire majority stake in US collagen brand Vital Proteins

Nestlé Health Science (NHSc) has agreed to acquire a majority stake in Vital Proteins, a US collagen brand and a lifestyle and wellness platform that manufactures supplements, beverages, and food products. Financial More...

By pharmanewsdaily On Sunday, February 9th, 2020

Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval

Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured an additional equity investment of $200 More...